Related Experiment Videos
Selective toxicity of deoxyadenosine analogues in human melanoma cell lines
Abstract:
The in vitro toxicities of 19 analogues of deoxyadenosine were tested using a panel of human melanoma cell lines including two lines sensitive to deoxyadenosine and deoxyinosine. The 2-fluoro-, 2-chloro-, 2-bromo- and 2-amino-8-aza derivatives were the most toxic and showed selectivity against deoxyadenosine-sensitive cells. 2-Bromodeoxyadenosine (BrdAdo) and its 5'-phosphate were less potent than the chloro compound but showed the greatest selectivity. In further studies of BrdAdo a third sensitive melanoma line was identified of the eight tested. A treatment time of 24 hr or more was required to develop toxicity to BrAdo; this could be prevented by deoxycytidine or cytidine added to the medium but not by other nucleosides. Flow cytometry showed that BrdAdo blocked cells in the G1 and S phases of the cell cycle. DNA synthesis as judged by thymidine incorporation was rapidly inhibited by BrdAdo to an extent which reflected the sensitivity of the particular cell line; RNA synthesis was less affected. Exposure to BrdAdo for 48 hr induced breaks in the preformed DNA of sensitive but not resistant cells. The results suggest that the toxicity of BrdAdo is associated with prolonged inhibition of DNA synthesis and subsequent DNA fragmentation.
Insights
Researchers tested deoxyadenosine analogues for toxicity against melanoma cells. 2-Bromodeoxyadenosine (BrdAdo) showed significant selectivity and toxicity by inhibiting DNA synthesis and causing fragmentation in sensitive cells.
Area of Science:
- Biochemistry
- Cancer Biology
- Pharmacology
Background:
- Deoxyadenosine analogues are investigated for potential anticancer properties.
- Melanoma cell lines exhibit varying sensitivities to nucleoside analogues.
Purpose of the Study:
- To evaluate the in vitro toxicity and selectivity of 19 deoxyadenosine analogues against human melanoma cell lines.
- To elucidate the mechanism of action for the most promising compounds, particularly 2-Bromodeoxyadenosine (BrdAdo).
Main Methods:
- In vitro cytotoxicity assays using a panel of human melanoma cell lines.
- Flow cytometry to analyze cell cycle effects.
- Assessment of DNA and RNA synthesis inhibition.
- DNA fragmentation analysis.
Main Results:
- Several 8-aza derivatives, including 2-fluoro-, 2-chloro-, 2-bromo-, and 2-amino-8-aza-deoxyadenosine, demonstrated potent toxicity and selectivity against deoxyadenosine-sensitive melanoma cells.
- 2-Bromodeoxyadenosine (BrdAdo) exhibited the greatest selectivity, requiring over 24 hours of exposure to induce toxicity.
- BrdAdo inhibited DNA synthesis, arrested cells in G1 and S phases, and led to DNA fragmentation in sensitive cell lines, while RNA synthesis was less affected.
Conclusions:
- The toxicity of BrdAdo is linked to sustained inhibition of DNA synthesis and subsequent DNA fragmentation.
- BrdAdo demonstrates potential as a selective agent against deoxyadenosine-sensitive melanoma cells, warranting further investigation.